AI assistant
SOLARA ACTIVE PHARMA SCIENCES LIMITED — Call Transcript 2022
Apr 25, 2022
61842_rns_2022-04-25_64d36f5f-5bf7-4693-86c3-d4c2d619b025.pdf
Call Transcript
Open in viewerOpens in your device viewer
Communication Address: Solara Active Pharma Sciences Limited 2nd Floor, Admin Block 27, Vandaloor Kelambakkam Road, Keelakottaiyur Village, Melakottaiyur (Post) Chennai – 600 127, India Tel : +91 44 43446700 Fax : +91 44 47406190 E-mail : [email protected] www.solara.co.in
Keelakottaiyur Village, Melakottaiyur (Post)
April 25, 2022
The BSE Limited The National Stock Exchange of India Limited Phiroze Jeejeebhoy Towers Exchange Plaza, Bandra-Kurla Complex Dalal Street, Mumbai – 400 001 Bandra (E), Mumbai – 400 051 Scrip Code: 541540 Scrip Code: SOLARA
Dear Sir / Madam,
Subject: Intimation of Analysts / Institutional Investors Conference Call
Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulation, 2015, kindly note that the Company, as part of investors engagement activities, has scheduled a conference call with the investors and analysts on Friday, April 29, 2022 at 3:30 pm IST to discuss its Q4 financial results. The conference call details are as follows:
| Event | Date & Time | Phone Numbers |
|---|---|---|
| Post Results Q4 FY22 | Friday, April 29, 2022, 3:30 pm | +91 22 6280 1346 |
| Conference Call | IST | +91 22 7115 8247 |
URL for prior (early) registration https://services.choruscall.in/DiamondPassRegistration/register?confirmationNumber=9048206&linkS ecurityString=265f9fe7a2
This is for your information and records.
Thanking you, Yours faithfully,
For Solara Active Pharma Sciences Limited
==> picture [146 x 39] intentionally omitted <==
S. Murali Krishna Company Secretary
Solara Active Pharma Sciences Limited - CIN : L24230MH2017PLC291636
REGD. OFF: 201, Devavrata, Sector 17, Vashi Navi Mumbai - 400703. India/ Tel: 91-22-2789 2924 / 2789 3199 / Fax: 91-22-2789 2942
Solara Q4FY22 Earnings Conference Call
Solara Active Pharma Sciences Limited (NSE: SOLARA; BSE: 541540), a leading Active Pharmaceutical Ingredient / CRAMS company will announce its results for the fourth quarter and 12 months ended March 31,2022 on April 29, 2022. Following the announcement, the senior management of the Company will host an Earnings Call for investors and analysts and the details of the call are:
==> picture [336 x 256] intentionally omitted <==
----- Start of picture text ----- 1530hrsIST+91 22 6280 1346+91 22 7115 8247----- End of picture text -----
==> picture [72 x 72] intentionally omitted <==
==> picture [73 x 74] intentionally omitted <==
Friday April 29 Pre-register here for diamond pass*